CONTEXT:Concern has been raised about the safety of assisted reproduction techniques for the offspring. OBJECTIVES:The objective of the study was to investigate postnatal growth and growth factors in children born after intra-cytoplasmatic sperm injection (ICSI) and in vitro fertilization (IVF). DESIGN:The study had two cohorts: a population-based longitudinal infant cohort 0-36 months [236 ICSI, 173 IVF, 1530 naturally conceived (NC)], and a cross-sectional child cohort at 5 yr (68 ICSI, 67 IVF, 70 NC). INTERVENTION:Anthropometrical measurements were made at birth, 3, 18, 36 (infant cohort), and 60 months (child cohort), and blood samples were collected at 3 or 60 months. MAIN OUTCOME MEASURES:Serum IGF-I, IGFBP-3, height, weight, head and abdominal circumference, body mass index, and fat folds were the main outcome measures. RESULTS:Anthropometrical measurements showed no significant differences between ICSI and IVF children and controls in either cohort. However, singleton ICSI girls [3.4 (0.6) kg, P = 0.008] had a slightly lower birth weight than IVF [3.5 (0.5) kg] and NC girls [3.5 (0.5) kg]. Birth weights of singleton boys [3.6 (0.5) kg], twin boys [2.6 (0.6) kg], and twin girls [2.4 (0.5) kg] did not differ between types of conception. In the infant cohort in 3-month-old singletons, serum IGF-I was lower in ICSI [78 (26) ng/ml] than NC boys [94 (27) ng/ml, P < 0.001] and IVF [74 (34) ng/ml], compared with NC girls [93 (43) ng/ml, P = 0.011]. ICSI children were also smaller than their target height (sd score) at 3 yr of age [mean -0.91 (1.2)], compared with NC children [-0.61 (0.9), P = 0.033]. In the child cohort, target height attainment (sd score) and growth factors did not differ among the three groups. CONCLUSIONS:The overall growth pattern of ICSI and IVF children in both cohorts was normal. Our findings of subtle differences in target height attainment and serum IGF-I levels between infants born after assisted reproduction techniques and controls may not be clinically significant. However, these observations indicate that further systematic follow-up of growth and puberty in these children is needed.

译文

背景:人们对后代辅助生殖技术的安全性表示关注。
目的:本研究的目的是调查胞浆内精子注射(ICSI)和体外受精(IVF)后出生的儿童的出生后生长和生长因子。
设计:该研究有两个队列:一个基于人群的纵向婴儿队列0-36个月[236 ICSI,173 IVF,1530自然受孕(NC)],以及一个横断面儿童队列,在5年时(68 ICSI,67 IVF ,70 NC)。
干预措施:分别在出生时,3、18、36(婴儿队列)和60个月(儿童队列)进行人体测量,并在3或60个月时采集血样。
主要观察指标:血清IGF-I,IGFBP-3,身高,体重,头围和腹围,体重指数和脂肪褶皱是主要的观察指标。
结果:人体测量结果显示,ICSI和IVF儿童与对照组之间均无显着差异。但是,单身ICSI女孩[3.4(0.6)千克,P = 0.008]的出生体重略低于IVF [3.5(0.5)千克]和NC女孩[3.5(0.5)千克]。单胎男孩[3.6(0.5)千克],双胞胎男孩[2.6(0.6)千克]和双胞胎女孩[2.4(0.5)千克]的出生体重在不同的受孕类型之间没有差异。在3个月大的单胎婴儿队列中,ICSI的血清IGF-I低于NC男孩[94(27)ng / ml,P <0.001]和IVF [74( 34)ng / ml],而NC女生则为[93(43)ng / ml,P = 0.011]。与3岁儿童相比,ICSI儿童在3岁时也小于其目标身高(sd评分)[平均-0.91(1.2)],而NC儿童则为[-0.61(0.9),P = 0.033]。在儿童队列中,三组之间的目标身高获得(sd得分)和生长因子没有差异。
结论:两组人群ICSI和IVF儿童的总体生长方式均正常。我们在辅助生殖技术和对照后出生的婴儿之间的目标高度获得和血清IGF-I水平细微差异的发现可能在临床上并不重要。但是,这些观察结果表明,需要对这些儿童的生长和青春期进行进一步的系统随访。

+1
+2
100研值 100研值 ¥99课程
检索文献一次
下载文献一次

去下载>

成功解锁2个技能,为你点赞

《SCI写作十大必备语法》
解决你的SCI语法难题!

技能熟练度+1

视频课《玩转文献检索》
让你成为检索达人!

恭喜完成新手挑战

手机微信扫一扫,添加好友领取

免费领《Endnote文献管理工具+教程》

微信扫码, 免费领取

手机登录

获取验证码
登录